Table 4 Comparison of clinical outcomes in NCAP and CAP control group according to macrolide containing regimens and non-macrolide regimens
From: Lung inflammatory pattern and antibiotic treatment in pneumonia
Clinical stability (days) | p# | LOS | p# | |
|---|---|---|---|---|
NCAP | ||||
-Macrolide regimens (n 23) | 8(6–12) | 0.007 | 12(10–21) | 0.007 |
-Non-macrolide regimens (n 29) | 14(8–27) | 20(13–36) | ||
CAP control | ||||
-Macrolide regimens (n 9) | 6(3–10) | 0.6 | 9(7–16) | 0.8 |
-Non-macrolide regimens (n 6) | 6(3–6) | 9(8–12) |